Vanguard Fiduciary Trust
QTTB icon

Vanguard Fiduciary Trust’s Q32 Bio QTTB Stock Holding History

Vanguard Fiduciary Trust’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$844K Buy
66,217
+16,222
+32% +$136K ﹤0.01% 3085
2026
Q1 		$321K Buy
+49,995
New +$238K ﹤0.01% 3357

Other funds holding QTTB

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust's QTTB Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Q32 Bio (QTTB) stake by 32% in Q2 2026, buying an estimated $136K and bringing the position to 66,217 shares worth $844K. The position accounts for ﹤0.01% of the portfolio, ranked #3085.

Vanguard Fiduciary Trust first reported a position in QTTB in Q1 2026 and has held it in 2 quarters since. 73 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • Vanguard Fiduciary Trust held 66,217 shares of Q32 Bio worth $844K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 16,222 Q32 Bio shares in Q2 2026, an estimated $136K.
  • Q32 Bio made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3085 holding.
  • Vanguard Fiduciary Trust first reported a position in Q32 Bio in Q1 2026 and has held it in 2 quarters since.
  • 73 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.